EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
63.50
+0.50 (0.79%)
At close: Mar 17, 2026
7.63% (1Y)
| Market Cap | 113.33M +21.6% |
| Revenue (ttm) | 9.37M +8.1% |
| Net Income | 2.38M +122.7% |
| EPS | 1.34 +122.5% |
| Shares Out | 1.78M |
| PE Ratio | 47.57 |
| Forward PE | n/a |
| Dividend | 1.83 (2.88%) |
| Ex-Dividend Date | n/a |
| Volume | 20 |
| Average Volume | 60 |
| Open | 63.50 |
| Previous Close | 63.00 |
| Day's Range | 63.50 - 63.50 |
| 52-Week Range | 56.00 - 65.50 |
| Beta | -0.07 |
| RSI | 53.26 |
| Earnings Date | Apr 21, 2026 |